Atrial natriuretic peptide and adiponectin interactions in man

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Birkenfeld, Andreas L ^a,b   Boschmann, Michael ^b   Engeli, Stefan ^d   Moro, Cedric ^c   Arafat, Ayman M ^a   Luft, Friedrich C ^b   Jordan, Jens ^d  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c University Hospital of Toulouse   (France)

^d HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ATRIAL NATRIURETIC FACTOR; GLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIALYSATE; HUMAN; HUMAN EXPERIMENT; LIPOLYSIS; MALE; MICRODIALYSIS; NORMAL HUMAN; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; VENOUS BLOOD;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; ATRIAL NATRIURETIC FACTOR; GLYCEROL; HUMANS; MALE;

EID: 84865095328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043238     Document Type: Article

References (21)

1. Khan AM, Cheng S, Magnusson M, Larson MG, Newton-Cheh C, et al. (2011) Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies. J Clin Endocrinol Metab 96: 3242-3249.
2. Magnusson M, Jujic A, Hedblad B, Engstrom G, Persson M, et al. (2011) Low Plasma Level of Atrial Natriuretic Peptide Predicts Development of Diabetes: The Prospective Malmo Diet and Cancer Study. J Clin Endocrinol Metab.
3. Wang TJ, Larson MG, Keyes MJ, Levy D, Benjamin EJ, et al. (2007) Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals. Circulation 115: 1345-1353.
4. Miyashita K, Itoh H, Tsujimoto H, Tamura N, Fukunaga Y, et al. (2009) Natriuretic peptides/cGMP/cGMP-dependent protein kinase cascades promote muscle mitochondrial biogenesis and prevent obesity. Diabetes 58: 2880-2892.
5. Meirhaeghe A, Sandhu MS, McCarthy MI, de GeP, Cottel D, et al. (2007) Association between the T-381C polymorphism of the brain natriuretic peptide gene and risk of type 2 diabetes in human populations. Hum Mol Genet 16: 1343-1350.
6. Lafontan M, Moro C, Berlan M, Crampes F, Sengenes C, et al. (2008) Control of lipolysis by natriuretic peptides and cyclic GMP. Trends Endocrinol Metab 19: 130-137.
7. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, et al. (2005) Lipid Mobilization with Physiological Atrial Natriuretic Peptide Concentrations in Humans. J Clin Endocrinol Metab 90: 3622-3628.
8. Tsukamoto O, Fujita M, Kato M, Yamazaki S, Asano Y, et al. (2009) Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. J Am Coll Cardiol 53: 2070-2077.
9. Ohara T, Hashimura K, Asakura M, Ogai A, Amaki M, et al. (2011) Dynamic changes in plasma total and high molecular weight adiponectin levels in acute heart failure. J Cardiol 58: 181-190.
10. Halberg N, Schraw TD, Wang ZV, Kim JY, Yi J, et al. (2009) Systemic fate of the adipocyte-derived factor adiponectin. Diabetes 58: 1961-1970.
11. Birkenfeld AL, Budziarek P, Boschmann M, Moro C, Adams F, et al. (2008) Atrial natriuretic peptide induces postprandial lipid oxidation in humans. Diabetes 57: 3199-3204.
12. Souza SC, Chau MD, Yang Q, Gauthier MS, Clairmont KB, et al. (2011) Atrial natriuretic peptide regulates lipid mobilization and oxygen consumption in human adipocytes by activating AMPK. Biochem Biophys Res Commun 410: 398-403.
13. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R, (2001) Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 507: 142-146.
14. Brunner-La Rocca HP, Kaye DM, Woods RL, Hastings J, Esler MD, (2001) Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects. J Am Coll Cardiol 37: 1221-1227.
15. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, et al. (2006) Beta-Adrenergic and Atrial Natriuretic Peptide Interactions on Human Cardiovascular and Metabolic Regulation. J Clin Endocrinol Metab 91: 5069-5075.
16. Scherer PE, (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 55: 1537-1545.
17. Sarzani R, Dessi-Fulgheri P, Paci VM, Espinosa E, Rappelli A, (1996) Expression of natriuretic peptide receptors in human adipose and other tissues. J Endocrinol Invest 19: 581-585.
18. Nakatsuji H, Maeda N, Hibuse T, Hiuge A, Hirata A, et al. (2010) Reciprocal regulation of natriuretic peptide receptors by insulin in adipose cells. Biochem Biophys Res Commun 392: 100-105.
19. Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, et al. (2005) Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112: 1756-1762.
20. Birkenfeld AL, Adams F, Schroeder C, Engeli S, Jordan J, (2011) Metabolic actions could confound advantageous effects of combined angiotensin II receptor and neprilysin inhibition. Hypertension 57: e4-e5.
21. Polak J, Kotrc M, Wedellova Z, Jabor A, Malek I, et al. (2011) Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls. J Am Coll Cardiol 58: 1119-1125.